PD-1/PD-L1 Immunotherapy Report

By www.reliablemarketsize.com

Report Details

Report Name

Global PD-1/PD-L1 Immunotherapy Industry Market Research Report Story

Pages

135

Price

$ 2960

Features

PD-1/PD-L1 Immunotherapy Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Jiangsu HengRui Medicine Co Ltd|||GlaxoSmithKline plc|||BeiGene Ltd|||Novartis AG|||Merck & Co Inc|||Bristol-Myers Squibb Company|||Sanofi S.A.|||Eli Lilly & Company|||Regeneron Pharmaceuticals Inc|||F. Hoffmann-La Roche Ltd|||AstraZeneca Plc|||Chia Tai Tianqing Pharmaceutical Group Co. Ltd|||Pfizer Inc|||Innovent Biologics Inc            

Countries Covered

              United States|||Canada|||Mexico|||Brazil|||China|||Japan|||Korea|||Southeast Asia|||India|||Australia|||Germany|||France|||UK|||Italy|||Russia|||Egypt|||South Africa|||Israel|||Turkey|||GCC            

Regions Covered

              North America|||Europe|||China|||Japan|||Middle East & Africa|||India|||South America|||Others            

Prices

Single User License:

$ 2960

Multi User License:

$ 4440

Enterprise/Corporate User License:

$ 5920